Prothena Reports Fourth Quarter and Full Year 2025 Financial Results, and Provides Financial Guidance and Business Highlights
Prothena's Partner Bristol Myers Squibb Obtains Fast Track Designation from the U.S. FDA for BMS-986446 , an Anti-MTBR-Tau-Targeting Antibody, for the Treatment of Alzheimer's Disease
Blackrock Silver Announces the Appointment of Bernard Poznanski and Susan Mathieu to the Board of Directors
Fortune Bay Drills Multiple Gold Zones at Goldfields including 6.61 g/t over 5.0 m within 2.54 g/t over 17.0 m
